登录
注册
馆藏资源
资讯公告
首 页
入馆指南
馆藏资源
学科专题
资讯公告
联系我们
更多>>
学科专题
A novel nanobody targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) receptor-binding domain has potent cross-neutralizing activity and protective efficacy against MERS-CoV
2020/2/20
Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA- liposome complex
2020/2/20
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein 寻找MERS解决方案：针对MERS-CoV棘突糖蛋白不同结构域和功能的保护性人单克隆抗体
2020/2/20
ope-CpG-DNA- liposome complex
2020/2/20
Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA- liposome complex 人中和单克隆抗体抑制中东呼吸系统综合征冠状病毒在普通绒猴体内的复制
2020/2/20
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV 抗MERS-CoV抗体肽双特异性融合蛋白的构建
2020/2/20
Coronaviruses - drug discovery and therapeutic options 冠状病毒-药物发现和治疗选择
2020/2/20
Broad-spectrum coronavirus antiviral drug discovery 广谱冠状病毒抗病毒药物的发现
2020/2/20
Small-molecule antiviral β-d-N 4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance 小分子抗病毒药物β-d-N 4-羟基胞苷（β-d-N 4-Hydroxycytidine）抑制具有高抗性遗传屏障的校对完整冠状病毒
2020/2/20
High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses 冠状病毒高效广谱抑制剂的高通量筛选与鉴定
2020/2/20
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
2020/2/20
«
320
321
322
323
324
»
